In the February, 1980 American Revenuer, Norman Rushefsky reported that Milliken founded his company in 1894 and tried to compete with Lambert Pharmacal Company's product, Listerine. Milliken's antiseptic was called Pasteurine, but it went nowhere.

The company went on to develop Amenotone, "a glandular preparation for female diseases," Formotropin for urinary tract infections, and Pava-Pepsin for indigestion. Milliken died in 1919, and in 1928 the firm was acquired by Abbott Laboratories, which "soon discarded most of the firm's products."

There are two known types of Milliken cancels that were used on battleship revenues. The other one is horizontal, in two lines.